UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 174

Sortiert nach

Pharmacovigilance of sodium-glucose co-transporter-2 inhibitors: What a clinician should know on disproportionality analysis of spontaneous reporting systems

Nutrition, metabolism, and cardiovascular diseases, 2018-06, Vol.28 (6), p.533-542

2018

Volltextzugriff (PDF)

Adverse cardiovascular events associated with triptans and ergotamines for treatment of migraine: Systematic review of observational studies

Cephalalgia, 2015-02, Vol.35 (2), p.118-131

2015

Volltextzugriff (PDF)

The value of case reports and spontaneous reporting systems for pharmacovigilance and clinical practice

British journal of dermatology (1951), 2021-03, Vol.184 (3), p.581-583

2021

Volltextzugriff (PDF)

Safety of esketamine nasal spray: Analysis of post-marketing reports submitted to the FDA adverse event reporting system in the first year on the market

European psychiatry, 2021-04, Vol.64 (S1), p.S150-S151

2021

Volltextzugriff (PDF)

Sudden cardiac and sudden unexpected death related to antipsychotics: A meta-analysis of observational studies

Clinical pharmacology and therapeutics, 2016-03, Vol.99 (3), p.306-314

2016

Volltextzugriff (PDF)

Pharmacovigilance analysis of the Vigibase on neonatal withdrawal syndrome following in utero exposure to antidepressants

European psychiatry, 2023-03, Vol.66 (S1), p.S96-S96

2023

Volltextzugriff (PDF)

Pharmacovigilance analysis of the Vigibase on antidepressants-related withdrawal syndrome in adults and adolescents

European psychiatry, 2023-03, Vol.66 (S1), p.S95-S96

2023

Volltextzugriff (PDF)

Neonatal withdrawal syndrome following in utero exposure to antidepressants: a disproportionality analysis of VigiBase, the WHO spontaneous reporting database

Psychological medicine, 2023-09, Vol.53 (12), p.5645-5653

2023

Volltextzugriff (PDF)

Adverse events with sodium-glucose co-transporter-2 inhibitors: A global analysis of international spontaneous reporting systems

Nutrition, metabolism, and cardiovascular diseases, 2017-12, Vol.27 (12), p.1098-1107

2017

Volltextzugriff (PDF)

The association of pancreatitis with antidiabetic drug use: gaining insight through the FDA pharmacovigilance database

Acta diabetologica, 2013-08, Vol.50 (4), p.569-577

2013

Volltextzugriff (PDF)

Dipeptidyl peptidase-4 inhibitors and heart failure: Analysis of spontaneous reports submitted to the FDA Adverse Event Reporting System

Nutrition, metabolism, and cardiovascular diseases, 2016-05, Vol.26 (5), p.380-386

2016

Volltextzugriff (PDF)

Toll-like receptor and antiphospholipid mediated thrombosis: in vivo studies

Annals of the rheumatic diseases, 2007-10, Vol.66 (10), p.1327-1333

2007

Volltextzugriff (PDF)

Infectious origin of the antiphospholipid syndrome

Annals of the rheumatic diseases, 2006-01, Vol.65 (1), p.2-6

2006

Volltextzugriff (PDF)

Safety Profile of Sodium-Glucose Co-Transporter-2 Inhibitors: A Global Analysis of Pharmacovigilance Databases

Clinical therapeutics, 2017-08, Vol.39 (8), p.e38-e39

2017

Volltextzugriff (PDF)

Association between the use of proton pump inhibitors and cardiovascular events: A note of caution

Neurogastroenterology and motility, 2017-02, Vol.29 (2), p.n/a

2017

Volltextzugriff (PDF)

Pattern of drug use among preterm neonates: results from an Italian neonatal intensive care unit

Italian journal of pediatrics, 2017-04, Vol.43 (1), p.37-9, Article 37

2017

Volltextzugriff (PDF)

Can authorities appreciably enhance the prescribing of oral generic risperidone to conserve resources? Findings from across Europe and their implications

BMC medicine, 2014-06, Vol.12 (1), p.98-98, Article 98

2014

Volltextzugriff (PDF)

Obstetric and vascular APS: Same autoantibodies but different diseases?

Lupus, 2012-06, Vol.21 (7), p.708-710

2012

Volltextzugriff (PDF)

Toll-like receptors: another player in the pathogenesis of the anti-phospholipid syndrome

Lupus, 2008-10, Vol.17 (10), p.938-943

2008

Volltextzugriff (PDF)

OP0285 The Pathogenic Role of Immune Complexes Containing Scleroderma-Specific Autoantibodies in the Inductor Phase of the Disease

Annals of the rheumatic diseases, 2015-06, Vol.74 (Suppl 2), p.180-180

2015

Volltextzugriff (PDF)

Liver injury with dipeptidyl peptidase-4 (DPP-4) inhibitors (GLIPTINS): signals emerging from the us-fda adverse event reporting system

Clinical therapeutics, 2015-08, Vol.37 (8), p.e106-e106

2015

Volltextzugriff (PDF)

Endothelial cell activation by antiphospholipid antibodies

Clinical immunology (Orlando, Fla.), 2004-08, Vol.112 (2), p.169-174

2004

Volltextzugriff (PDF)

Toll-like receptor 4 and β2 glycoprotein I interaction on endothelial cells

Lupus, 2014-10, Vol.23 (12), p.1302-1304

2014

Volltextzugriff (PDF)

Pathogenesis of antiphospholipid syndrome: understanding the antibodies

Nature reviews. Rheumatology, 2011-06, Vol.7 (6), p.330

2011

Volltextzugriff (PDF)

Pathogenic role of anti-β2-glycoprotein I antibodies in antiphospholipid associated fetal loss: characterisation of β2-glycoprotein I binding to trophoblast cells and functional effects of anti-β2-glycoprotein I antibodies in vitro

Annals of the rheumatic diseases, 2005-03, Vol.64 (3), p.462-467

2005

Volltextzugriff (PDF)

1 – 25 von 174

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(151)
Mit Volltextzugriff
(151)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(79)
Life Sciences & Biomedicine
(74)
Humans
(63)
Biological And Medical Sciences
(30)
Animals
(29)
Female
(26)
Medical Sciences
(23)
Male
(19)
Pharmacovigilance
(18)
Antibodies, Antiphospholipid - Immunology
(17)
Immunology
(17)
Antiphospholipid Syndrome - Immunology
(16)
Beta 2-Glycoprotein I
(16)
Adult
(15)
Glycoproteins - Immunology
(14)
Endothelium, Vascular - Immunology
(13)
Medicin Och Hälsovetenskap
(13)
Life Sciences
(12)
Pharmacology & Pharmacy
(12)
Rheumatology
(12)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Pharmacovigilance of sodium-glucose co-transporter-2 inhibitors: What a clinician should know on disproportionality analysis of spontaneous reporting systems

Adverse cardiovascular events associated with triptans and ergotamines for treatment of migraine: Systematic review of observational studies

The value of case reports and spontaneous reporting systems for pharmacovigilance and clinical practice

Safety of esketamine nasal spray: Analysis of post-marketing reports submitted to the FDA adverse event reporting system in the first year on the market

Sudden cardiac and sudden unexpected death related to antipsychotics: A meta-analysis of observational studies

Pharmacovigilance analysis of the Vigibase on neonatal withdrawal syndrome following in utero exposure to antidepressants

Pharmacovigilance analysis of the Vigibase on antidepressants-related withdrawal syndrome in adults and adolescents

Neonatal withdrawal syndrome following in utero exposure to antidepressants: a disproportionality analysis of VigiBase, the WHO spontaneous reporting database

Adverse events with sodium-glucose co-transporter-2 inhibitors: A global analysis of international spontaneous reporting systems

The association of pancreatitis with antidiabetic drug use: gaining insight through the FDA pharmacovigilance database

Dipeptidyl peptidase-4 inhibitors and heart failure: Analysis of spontaneous reports submitted to the FDA Adverse Event Reporting System

Toll-like receptor and antiphospholipid mediated thrombosis: in vivo studies

Infectious origin of the antiphospholipid syndrome

Safety Profile of Sodium-Glucose Co-Transporter-2 Inhibitors: A Global Analysis of Pharmacovigilance Databases

Association between the use of proton pump inhibitors and cardiovascular events: A note of caution

Pattern of drug use among preterm neonates: results from an Italian neonatal intensive care unit

Can authorities appreciably enhance the prescribing of oral generic risperidone to conserve resources? Findings from across Europe and their implications

Obstetric and vascular APS: Same autoantibodies but different diseases?

Toll-like receptors: another player in the pathogenesis of the anti-phospholipid syndrome

OP0285 The Pathogenic Role of Immune Complexes Containing Scleroderma-Specific Autoantibodies in the Inductor Phase of the Disease

Liver injury with dipeptidyl peptidase-4 (DPP-4) inhibitors (GLIPTINS): signals emerging from the us-fda adverse event reporting system

Endothelial cell activation by antiphospholipid antibodies

Toll-like receptor 4 and β2 glycoprotein I interaction on endothelial cells

Pathogenesis of antiphospholipid syndrome: understanding the antibodies

Pathogenic role of anti-β2-glycoprotein I antibodies in antiphospholipid associated fetal loss: characterisation of β2-glycoprotein I binding to trophoblast cells and functional effects of anti-β2-glycoprotein I antibodies in vitro

Suchergebnisse filtern